News
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.
An expert sat down to discuss the emotional and physical barriers patients may face when seeking support for fear of cancer ...
It’s spring, a time for new beginnings following a cancer diagnosis; however, I have an ongoing issue that I can’t dismiss.
The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.
The Oncodetect test detects molecular residual disease across solid tumors using circulating tumor DNA to inform recurrence ...
Dr. Matthew Galsky discusses the FDA approval of Imfinzi and chemo before and after surgery for muscle-invasive bladder ...
Don’t aspire to make a living. Let’s aspire to make a difference in the Mandarin/Cantonese-speaking community.” ...
Carly Stafford Dixon, a rare cancer survivor, highlights the need for AYA cancer awareness to improve support, visibility and access to vital resources.
Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian ...
I share my unique aggressive treatment journey over 11 years, highlighting a common hope for more time and better treatments.
Enhertu plus Perjeta demonstrated improvement in progression-free survival versus standard treatment in HER2-positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results